T 1123/16 (Eosinophilic bronchitis/GLAXO) of 13.04.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T112316.20210413
- Date of decision
- 13 April 2021
- Case number
- T 1123/16
- Petition for review of
- -
- Application number
- 09725345.4
- IPC class
- C07K 16/24A61K 39/395
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Methods of treatment
- Applicant name
- GlaxoSmithKline LLC
- Opponent name
- Urquhart-Dykes & Lord LLP
Cephalon, Inc. - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 13
- Keywords
- Inventive step - reasonable expectation of success (yes)
Inventive step - main request and auxiliary requests 1, 2 and 4
Late-filed auxiliary request 3 - admitted (no) - Catchword
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.